Last reviewed · How we verify

NCT05267847

The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible Pulpitis

Status unknown NA Last updated 4 March 2022
What this trial tests

NA trial testing Cryotherapy in Pain, Procedural in 188 participants. Status unknown.

Timeline
22 February 2022
Primary endpoint
30 April 2022
30 April 2022

Quick facts

Lead sponsorMinia University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment188
Start date22 February 2022
Primary completion30 April 2022
Estimated completion30 April 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 5 to 9, any sex, with Pain, Procedural. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed as a randomized controlled trial with two parallel groups. Children aged 5-9 years with primary molars from suffered symptomatic signs of irreversible pulpitis will be randomly assigned into two groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block). For the second group, the mandibular second primary molars will be anesthetized using 4% articaine 1:100.000 epinephrine using inferior alveolar nerve block.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cryotherapy and pain intensity during endodontic treatment of mandibular first permanent molars with symptomatic irreversible pulpitis: A randomized controlled trial.
    Elheeny AAH, Sermani DI, Saliab EA, Turky M. · · 2023 · cited 6× · PMID 37268843 · DOI 10.1007/s00784-023-05084-1

Verify or expand the search:

Other trials of Cryotherapy

Trials testing the same drug.

Other recruiting trials for Pain, Procedural

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05267847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing